Overview
- Annals of Internal Medicine published a new secondary analysis on August 25, 2025, reporting results from PREDIMED-Plus, Europe’s largest nutrition and lifestyle randomized trial.
- The study followed 4,746 adults aged 55–75 in Spain with overweight or obesity and metabolic syndrome, comparing an energy-reduced Mediterranean diet plus activity and professional support to an ad libitum Mediterranean diet.
- The intervention targeted about a 600‑kilocalorie daily deficit and roughly 45 minutes of moderate aerobic activity most days, with added strength and balance work and regular dietitian coaching.
- Type 2 diabetes incidence was 31% lower in the intervention group, translating to about three fewer cases per 100 participants over six years.
- Average changes included about 3.3 kilograms of weight loss and a 3.6‑centimeter smaller waist in the intervention group versus 0.6 kilograms and 0.3 centimeters in controls, and accompanying commentary notes potential challenges to scaling such support outside Mediterranean settings.